Status:
NOT_YET_RECRUITING
Effectiveness and Safety of Limbal Relaxing Incisions for Correcting Post Phacoemulsification High Astigmatism
Lead Sponsor:
Assiut University
Conditions:
Astigmatism
Phacoemulsification
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
To compare the effect of Limbal relaxing incisions (LRIs) plus spectacle correction versus spectacle correction alone on subjective and objective improvement in visual function for correcting post pha...
Detailed Description
Astigmatism is one of the commonest refractive errors encountered during our clinical practice. Surgically induced astigmatism is the main obstacle to achieve good uncorrected visual acuity following ...
Eligibility Criteria
Inclusion
- Conventional phacoemulsification was done at least one month earlier.
- Clear cornea with corneal astigmatism more than 3.0 D.
Exclusion
- History of corneal surgeries (e.g., keratoplasty, refractive surgery, and corneal wound repair).
- Ocular trauma.
- Other intraocular surgery.
- Patient with corneal opacities.
- Thin cornea .
- Any significant ocular disease causing diminution of vision (e.g., optic atrophy, diabetic retinopathy, and age-related macular degeneration), autoimmune disease, and peripheral corneal disease.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06896357
Start Date
May 1 2025
End Date
June 1 2026
Last Update
March 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.